Product logins

Find logins to all Clarivate products below.


Cardiac Rhythm Management Devices | Market Insights | Europe | 2024

The European CRM device market will continue to experience modest growth through 2032, primarily due to increasing adoption of premium-priced devices such as leadless pacemakers and S-ICDs. However, revenue growth will be limited to some extent by ASP declines caused by increasing competition in the leadless pacemaker and S-ICD markets.

This Medtech 360 Report provides comprehensive data and analysis on the state of the European CRM device market from 2019 through 2032.

Related Medtech Insights Reports

Report
Dental Bone Graft Substitutes – Market Insights – Global
The overall dental BGS market is poised for moderate growth over the forecast period. The market is primarily driven by an increasing aging population, which is increasing the prevalence of dental…
Report
Dental Implants – Market Insights – Latin America (Supplemental)
The Latin American dental implant market will expand throughout the forecast period. The market is primarily driven by the expanding aging population, rising oral health awareness in some countries…
Report
Cardiac Assist Devices – Market Insights – United States
The US cardiac assist device market, although encumbered by recurring device recalls, will continue to grow rapidly due to new product development, the availability and expanded use of devices for…
Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in the Asia-Pacific will experience modest growth through 2033. This growth will be fueled by an increasing number of surgical interventions that require biosurgical…
Report
Biosurgical Agents – Market Insights – Japan
The Japanese biosurgical agent market is projected to demonstrate a modest growth over the forecast period, driven by the rising volume of surgical procedures and heightened awareness of the…